These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 33603714

  • 1. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery.
    Chen F, Zhou Y, Wu Z, Li Y, Zhou W, Wang Y.
    Front Endocrinol (Lausanne); 2020; 11():611213. PubMed ID: 33603714
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Key genes involved in nonalcoholic steatohepatitis improvement after bariatric surgery.
    Chen X, Deng SZ, Sun Y, Bai Y, Wang Y, Yang Y.
    Front Endocrinol (Lausanne); 2024; 15():1338889. PubMed ID: 38469144
    [Abstract] [Full Text] [Related]

  • 4. Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis.
    Mazzini GS, Khoraki J, Dozmorov M, Browning MG, Wijesinghe D, Wolfe L, Gurski RR, Campos GM.
    J Gastrointest Surg; 2019 Jan; 23(1):51-57. PubMed ID: 30206765
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
    Li LY, Wu JX.
    Zhonghua Yi Xue Za Zhi; 2021 Nov 02; 101(40):3317-3322. PubMed ID: 34758532
    [Abstract] [Full Text] [Related]

  • 7. Treatment of NASH with Gastric Bypass.
    Jirapinyo P, Thompson CC.
    Curr Gastroenterol Rep; 2018 Sep 22; 20(10):49. PubMed ID: 30244334
    [Abstract] [Full Text] [Related]

  • 8. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV, Rodriguez NA, Vangoitsenhoven R, Singh T, Mehta N, McCullough AJ, Brethauer SA, Schauer PR, Aminian A.
    Surg Endosc; 2020 May 22; 34(5):2266-2272. PubMed ID: 31359195
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J, Liu H, Xie G, Cai W, Xu J.
    Mol Med Rep; 2020 Feb 22; 21(2):685-694. PubMed ID: 31974594
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, Wróblewski T, Remiszewski P, Grodzicki M, Krawczyk M.
    Ann Surg; 2017 Nov 22; 266(5):738-745. PubMed ID: 28767558
    [Abstract] [Full Text] [Related]

  • 15. Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score-Matched Analysis.
    Abbassi Z, Orci L, Meyer J, Sgardello SD, Goossens N, Rubbia-Brandt L, Spahr L, Buchs NC, Mönig SP, Toso C, Hagen ME, Jung MK.
    Obes Surg; 2022 Jan 22; 32(1):74-81. PubMed ID: 34546514
    [Abstract] [Full Text] [Related]

  • 16. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D, Corcelles R, Daigle C, Boules M, Brethauer S, Schauer P.
    Surg Obes Relat Dis; 2016 Jan 22; 12(1):127-31. PubMed ID: 26077701
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.
    Fan GH, Wei RL, Wei XY, Zhang CZ, Qi ZT, Xie HY, Zheng SS, Xu X.
    Hepatobiliary Pancreat Dis Int; 2021 Oct 22; 20(5):433-451. PubMed ID: 34233850
    [Abstract] [Full Text] [Related]

  • 20. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery.
    Zhang X, Li J, Liu T, Zhao M, Liang B, Chen H, Zhang Z.
    Dis Markers; 2022 Oct 22; 2022():4369329. PubMed ID: 35789605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.